Area of research
Epidemiology · Oncology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Head and Neck Cancer Studies, and Neuroblastoma Research and Treatments.
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.
<i>TERT</i> Expression and Clinical Outcome in Pulmonary Carcinoids.
Exploring the antiproliferative effect of PI3K/Akt/mTOR pathway and CDK4/6 inhibitors in human papillomavirus‑positive and ‑negative head and neck squamous cell carcinoma cell lines.
OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid.
The significance of <scp>PAX5</scp> in Merkel cell carcinoma
Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis.
Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications.
Controversies in NEN: An ENETS position statement on the treatment of patients with Grade 3 well-differentiated neuroendocrine tumours of the gastro-enteropancreatic tract.
Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma.
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC.
Deep Learning-Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin-Stained Specimens.
The significance of PAX5 in Merkel cell carcinoma.
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics.
A Response to the Letter to the Editor: "Linear Versus Non-Linear: Debunking Critiques on PCA Use in Molecular Subgrouping of Pulmonary Carcinoids".
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter Study.
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
Disease relapse in relation to lymph node sampling in lung carcinoid patients.
Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure?
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study
Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues.
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.
Proximity ligation-based sequencing for the identification of human papillomavirus genomic integration sites in formalin-fixed paraffin embedded oropharyngeal squamous cell carcinomas.
RETRACTED: Characterization of therapeutic effects in Glioblastoma through integrated spatial single-cell multiome profiling of longitudinal samples: unveiling clinically relevant subtypes of pathological changes
Detection of <i>PTCH1</i> Copy-Number Variants in Mosaic Basal Cell Nevus Syndrome.
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites.